baber/WOPTO huggingface dataset:
Patent JP-4291884-B2 (JP)
IPC: C12N9/12
Filed: 1998-08-12
Granted: 2009-07-08
Abstract: There is provided use of a reovirus for the manufacture of a medicament for treating a neoplasm in a mammal, wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted in the neoplasm. <IMAGE>
Patent JP-4080539-B2 (JP)
IPC: A01N37/44
Filed: 1997-09-22
Granted: 2008-04-23
Abstract: A compound, compound (I), is disclosed which inhibits ethylene production in plants. In addition, aqueous formulations comprising compound (I) are disclosed as well as methods of applying formulations comprising compound (I) to plants.
Patent JP-2869186-B2 (JP)
IPC: A01N25/30
Filed: 1990-10-17
Granted: 1999-03-10
Abstract: Methods and compositions are provided for enhancing uptake of a plant active agent, particularly herbicides, which have structures capable of equilibrating to acidic and basic species in the presence of water. The bioactive agent is mixed with an uptake and transport-enhancing adjuvant comprising an anionic surfactant and a mixture of water-immiscible, low-vapor pressure, vegetable-derived oils.
Patent JP-4792149-B2 (JP)
IPC: A61K47/10
Filed: 1998-09-08
Granted: 2011-10-12
Abstract: A particle coated with a nonlamellar crystalline material includes an internal matrix core having at least one nanostructured liquid phase, or at least one nanostructured liquid crystalline phase or a combination of the two is used for the delivery of active agents such as pharmaceuticals, nutrients, pesticides, etc. The coated particle can be fabricated by a variety of different techniques where the exterior coating is a nonlamellar crystalline material.
Patent JP-3195793-B2 (JP)
IPC: A61P1/00
Filed: 1991-07-30
Granted: 2001-08-06
Abstract: The invention in growth factor compositions includes: a novel compound which is a separate pure nicked or pure non-nicked species of epidermal growth factor EGF1-48 or its hEGF1-47 or hEGF1-49 congener compound, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition in dosage form comprising an effective amount of the novel compound; and use thereof for treating abnormal cell growth conditions including gastrointestinal/duodenal lesions; and methods of making the pure hEGF species. This unique therapeutic utility is enhanced by the unexpected and heretofore unappreciated structural stability and resistance of the pure species to enzymatic degradation.
Patent JP-3889438-B2 (JP)
IPC: C12N15/09
Filed: 1995-11-15
Granted: 2007-03-07
Abstract: The present invention relates to an enzyme process for the one-step conversion of cephalosporin C or a derivative thereof into 7-aminocephalosporanic acid or a corresponding derivative thereof. The one step conversion is effected using a cephalosphorin C amidohydrolase derived from Pseudomonas Vesicularis B965, or from any cephalosporin C amidolydrolase producing or potentially producing descendants thereof, or from expression of DNA derived from Pseudomonas Vesicularis B965 or any cephalosporin C amidohydrolase producing or potentially producing descendants thereof.
Patent JP-3230239-B2 (JP)
IPC: A61K35/08
Filed: 1991-10-16
Granted: 2001-11-19
Abstract: PCT No. PCT/FR91/00805 Sec. 371 Date Jun. 4, 1993 Sec. 102(e) Date Jun. 4, 1993 PCT Filed Oct. 16, 1991 PCT Pub. No. WO92/06666 PCT Pub. Date Apr. 30, 1992.The present invention relates to compositions based on thermal water containing liposomes of thermal water stabilized in a deoxyribonucleic acid (DNA) gel and a process for preparing thereof. The composition is useful in dermatology and cosmetology.
Patent JP-3755007-B2 (JP)
IPC: G01N31/22
Filed: 1995-12-14
Granted: 2006-03-15
Abstract: A multilayer analytical element for determining a level of an analyte on a substrate and adapted for use with hydrogen peroxide and an affinity-enzymatic compound of formula A-C-B, wherein A is a detecting agent having affinity for the analyte, B is an enzymatic visualizing agent consisting of peroxidase and C is a binding agent linking the detecting and visualizing agents together. The multilayer analytical element of the invention comprises a solid support and a hydrophilic layer thereon, the hydrophilic layer being formed of gelatin, polyvinyl alcohol or a mixture thereof and containing a developing agent and a hydrophobic color-producing agent in a total amount of 5 to 30 weight %, the developing agent and the color-producing agent being present in a weight ratio of 1:0.3 to 1:3.0. The developing agent is capable of undergoing oxidation by the hydrogen peroxide in the presence of the peroxidase bound via the binding and detecting agents to the analyte on the substrate, whereby the developing agent in oxidized form reacts with the color-producing agent to form a colored product having a color indicative of the level of analyte.
Patent JP-3288706-B2 (JP)
IPC: F16H61/02
Filed: 1994-02-17
Granted: 2002-06-04
Abstract: PCT No. PCT/FR94/00177 Sec. 371 Date Oct. 16, 1995 Sec. 102(e) Date Oct. 16, 1995 PCT Filed Feb. 17, 1994 PCT Pub. No. WO94/19624 PCT Pub. Date Sep. 1, 1994A transmission apparatus in which a differential-type transmission device has rotating elements with intermeshing teeth, one of which elements is connected to an input shaft and the other to an output shaft. One of the rotating elements is a reaction element, and the transmission apparatus has a selective locking mechanism mounted operatively between the reaction element and a housing of the transmission apparatus. The selective locking mechanism has a free-wheel for enabling the reaction element to rotate in the same direction as the input shaft and the output shaft when a selective connection device connects the rotating elements of said differential mechanism in order to cause direct drive operation. When the freewheel is locked, the reaction element is integral in rotation with a rotor of a brake which is able to be selectively released in order to release the rotor and the reaction element in relation to said housing. In a neutral condition the brake allows the reaction element to rotate in an opposite direction. The brake is furthermore able to be selectively and gradually activated so as to gradually immobilize the rotor in relation to the housing, whereby the reaction element is then selectively immobilized and allowed to rotate in the same direction as the input and output shafts.
Patent JP-3732510-B2 (JP)
IPC: G02B21/32
Filed: 1995-03-01
Granted: 2006-01-05
Abstract: A method of direct extraction of cellular material from a tissue sample which involves: forming an image field of cells of the tissue sample utilizing a microscope, identifying at least one zone of cells of interest from the image field of cells which at least one zone of cells of interest includes different types of cells than adjacent zones of cells, and extracting the at least one zone of cells of interest from the tissue sample. The extracted zone(s) of cells is subjected to analysis. The overall process of identifying, extracting, transporting, and analyzing the extracted zones(s) of cells can be fully automated.
Patent JP-3202991-B2 (JP)
IPC: B65D85/00
Filed: 1994-06-29
Granted: 2001-08-27
Abstract: An enclosed semiconductor wafer holder, and a cover providing isolation control of semiconductor wafers that is simple, lower cost, and non-obtrusive is described. The cover includes a sealing perimeter that creates a hermetic seal when engaged with the semiconductor wafer holder. The holder also includes a purging arrangement attached to the holder that allows an active gentle purging of inert gas into the sealed semiconductor wafer holder.
Patent JP-3762790-B2 (JP)
IPC: C07D401/12
Filed: 1997-02-07
Granted: 2006-04-05
Abstract: This invention is directed to benzamidine derivatives substituted by amino acid and hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Patent JP-3650939-B2 (JP)
IPC: G01N33/68
Filed: 1997-05-07
Granted: 2005-05-25
Abstract: This invention relates to the use of urine ABP measurement in the diagnosis of serious systemic infection, and in the determination of increased chance of mortality.
Patent ES-2396840-B2 (ES)
Title: Procedimiento y dispositivo de compresión-inyección y pieza de revestimiento o decorativa obtenida para automóvil.
Inventor: DUTOUQUET DENIS
IPC: B29C43/14
Filed: 2010-10-14
Granted: 2014-07-02
Abstract: Procedimiento y dispositivo de compresión-inyección y pieza de revestimiento o decorativa obtenida para automóvil.#La presente invención tiene por objeto un procedimiento de transformación de material plástico combinando la compresión de una preforma (1) e inyección de un material plástico y que consiste, entre otros, en posicionar precisamente la preforma (1), y comprimirla antes del cierre parcial del molde (3). La invención también tiene por objeto un dispositivo de aplicación de este procedimiento, incluyendo un medio de posicionamiento. Por último, la invención tiene por objeto una pieza obtenida por este procedimiento y este dispositivo, y en que la parte inyectada completa la forma global de la cubierta final. Aplicación de piezas de revestimiento o decoración para la cabina de un automóvil y su fabricación.
Patent ES-2368325-B2 (ES)
Title: Sistema y dispositivo condensador de recogida de agua del medio ambiente.
Inventor: MUNOZ GARCIA MIGUEL ANGEL
IPC: A01G25/00
Filed: 2011-06-20
Granted: 2012-03-23
Abstract: Sistema y dispositivo condensador para la recogida de agua del medio ambiente. El dispositivo condensador (26) comprende:#- dos células peltier (1,2);#- medios disipadores de calor (4) en contacto con la cara caliente de las células peltier (1,2);#- una superficie de condensación (6) en contacto con la cara fría de las células peltier (1,2);#- un habitáculo (9) para alojar las células peltier (1,2), delimitando una cámara fría (10) y una cámara caliente (11), con aberturas para la salida del aire (13,15) en ambas cámaras (10,11) y abertura regulable (14) para la entrada de aire en la cámara fría (10);#- medios sensores de humedad relativa (17) y de temperatura (16) del aire en el interior de la cámara fría (10);#- medios sensores de temperatura (7) de la superficie de condensación (6);#- medios de recogida (18,19,20,21) del agua condensada en la superficie de condensación (6).
Patent ES-2401447-B2 (ES)
Title: Aparato para crear uno o más canales de comunicaciones de baja velocidad utilizando un canal de comunicación en tiempo real
Inventor: LEE TONY J
IPC: H04L27/00
Filed: 2011-03-22
Granted: 2014-12-04
Abstract: Un dispositivo electrónico inteligente crea uno o más canales de comunicaciones virtuales, usando bits no usados o dedicados provenientes de un canal primario de comunicaciones en tiempo real. Los canales de comunicaciones virtuales son usados para transportar información de baja velocidad, tal como comandos ejecutables, o funciones automáticas que no requieran un alto ancho de banda.
Patent AU-2001270405-B2 (AU)
Title: Polymeric micelle compositions
Inventor: BENAHMED AMINA SOUAD
IPC: A61K31/407
Filed: 2001-06-28
Granted: 2005-01-20
Abstract: Novel polymeric micelles which are used to deliver therapeutic agents, including anti tumor drugs.
Patent AU-2001289839-B2 (AU)
Title: Device for transporting people by a spreader
Inventor: FALLER HEIDE
IPC: B66F11/04
Filed: 2001-08-27
Granted: 2007-06-28
Abstract: An apparatus for transporting people by a spreader having a vertically moveable head beam with a pair of horizontally extendable long bars includes a pair of personnel cages carried by a pair of cantilever beams extending from a housing. The personnel cages can be mounted to free ends of the long bars and be moved vertically with respect to the spreader.
Patent AU-2002316738-B2 (AU)
Title: Pharmaceutical combinations of oxycodone and naloxone
Inventor: COLUCCI ROBERT D
IPC: A61K9/00
Filed: 2002-07-18
Granted: 2009-01-08
Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising from 10 to 40 mg of oxycodone or a pharmaceutically acceptable salt thereof and 0.65 to 0.90 mg naloxone or a pharmaceutically acceptable salt thereof.
Patent AU-2002317329-B2 (AU)
Title: Variolin derivatives and their use as antitumor agents
Inventor: POZO CARLOS DEL
IPC: A61K31/53
Filed: 2002-07-11
Granted: 2008-10-02
Abstract: Variolin derivatives of formula (5) are provided, wherein the substituent groups defined by X 2 , R 1 , R 2 , R 3 , R 6 , R 7  and R 12  are each independently selected from the group consisting ofH, OH, OR', SH, SR', SOR', SO 2 R', NO 2 , NH 2 , NHR' (N(R') 2 , NHCOR', NHSO 2 R', CN, halogen, =O C(=O)H, C(=O)R', CO 2 H, CO 2 R', carboxyalkyl, C 1-12  alkyl, C 2 -C 12  alkenyl, C 2 -C 12  alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl and substituted or unsubstituted heteroaromatic; wherein each of the R' groups is independently selected from the group consisting of H, OH, SH, NO 2 , NH 2 , CN, halogen, =O, C(=O)H, C(=O)CH 3 , CO 2 H, CO 2 CH 3 , C 1 -C 12  alkyl, C 2 -C 12  alkenyl, C 2 -C 12  alkynyl, aryl, aralkyl and heteroaromatic; wherein the pairs of groups R 1  and R 2 , R 2  and R 3 , R 3  and R 12 , R 12  and R 6 , or R 6  and R 7  may be joined into a carbocyclic or heterocyclic ring system.
Patent AU-2003231750-B2 (AU)
Title: Heat transfer tubes, including methods of fabrication and use thereof
Inventor: TYLER TOMMY
IPC: F28F13/18
Filed: 2003-04-21
Granted: 2008-05-01
Abstract: The present invention discloses an improved heat transfer tube, an improved method of formation, and an improved use of such heat transfer tube. The present invention discloses a boiling tube for a refrigerant evaporator that provides at least one dual cavity nucleate boiling site. The present invention further discloses an improved refrigerant evaporator including at least one such boiling tube, and the method of making such a boiling tube.
Patent AU-2003243004-B2 (AU)
Title: Sn-based metal-coated steel strip excellent in appearance and process for producing same
Inventor: IZAKI TERUAKI
IPC: C23C2/02
Filed: 2003-06-20
Granted: 2006-10-26
Abstract: A Sn-based metal-coated steel strip excellent in appearance comprises a Ni-based metal (such as Ni, a Ni-Sn alloy, a Ni-Zn alloy, a Ni-Fe alloy and a Ni-Co alloy) preplating layer and a Sn-based metal (such as a Sn-Zn alloy) coating formed thereon, and is characterized in that a Ni emission intensity line and an Fe emission intensity line obtained by glow discharge spectroscopy of the surface of the coated steel strip satisfy a relationship of the formula: T 1 >=T 2 wherein T 1 is a sputtering time at the peak of a Ni emission intensity line, and T 2 is a sputtering time at the inflection point of an Fe emission intensity line, or a relationship of the formulas: T 1 >=T 2 , and 1<=T 1 /T 2 <=1.5
Patent AU-2003251002-B2 (AU)
Title: Bisacyloxypropylcysteine conjugates and the use thereof
Inventor: MUHLRADT PETER
IPC: A61K47/48
Filed: 2003-07-18
Granted: 2009-02-26
Abstract: Bisacyloxypropylcysteine conjugates (I) are new. Bisacyloxypropylcysteine conjugates of formula (R 2-COO-CH(-CH 2-OOC-R 1)-CH 2-S-CH 2-CH(NH 2)-CO-Y 1-R 3) (I) are new. R 1, R 2carboxyl group bounded fatty acid residues; Y 1-NH-, -O-, -S- or -OCO-; R 3covalently or ionically bound conjugate comprising water-soluble and physiological compatible, covalent or ionically bound polymer, preferably covalently bound polyethylene glycol (polyoxyethylene) of formula (-(CH 2-CH 2-O) m-CH 2-CH 2-X), polyoxyethylene-polyoxypropylene-copolymer, dextran, sugar, polyvinylpyrrolidone, alginate, pectin or collagen (where the polymer residue R 3 is mono-, di-, or multi-substituted by a group of formula (R 2-COO-CH(-CH 2-OOC-R 1)-CH 2-S-CH 2-CH(NH 2)-CO-Y 1-)); X : OR, NR 2, SR or COOR; R : H, benzyl or 1-6C alkyl; and m : 5-700, preferably 100-500. ACTIVITY : Antimicrobial; Immunostimulant; Cytostatic; Antibacterial; Immunosuppressive; Vulnerary; Antiallergic; Antiinflammatory. MECHANISM OF ACTION : None given.
Patent AU-2003301277-B2 (AU)
Title: 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
Inventor: COLPAERT FRANCIS
IPC: C07D405/12
Filed: 2003-10-16
Granted: 2009-06-18
Abstract: Cyclopentenyl benzyl or heteroaryl amines (I) are new. Cyclopentenyl benzyl or heteroaryl amines of formula (I) and their salts and salt hydrates, their tautomeric and enantiomeric forms, and mixtures, including racemic mixtures, are new. a = single or double bond; W = CH, CH2, CHCH3, CCH3, C(CH3)2, C(CH2)2 (forming a spiro-cyclopropane ring), or C(CH2)3 (forming a spiro-cyclobutane ring); X = CH or N; Y = H or F. An Independent claim is also included for intermediates of formula (II).
Patent AU-2004256354-B2 (AU)
Title: IgM production by transformed cells and methods for quantifying said IgM production
Inventor: REIKO IRIE
IPC: C07K16/00
Filed: 2004-07-15
Granted: 2011-07-07
Abstract: Pentamer IgM can be obtained by locating genes respectively encoding H chain, L chain and J chain on a single vector and then transforming into an appropriate host cell. The gene encoding J chain may be transferred via cotransformation. In the case where the J chain is not expressed, the product is obtained as hexamer IgM. The transformant thus obtained shows a high IgM productivity. It is also intended to provide a method whereby a polymer IgM can be separated and quantified.
Patent AU-2004259206-B2 (AU)
Title: Devices and methods for treating aortic valve stenosis
Inventor: LAIRD ROB
IPC: A61F2/958
Filed: 2004-07-16
Granted: 2009-12-17
Abstract: Fluid delivery devices having a porous applicator, as well as methods for using the same in the treatment of aortic valve stenosis, are provided. The subject devices further include a ventricular occlusion balloon and a compliant element that is configured to envelope the occlusion balloon. Also provided are systems and kits that include the subject fluid delivery devices.
Patent AU-2004263179-B2 (AU)
Title: Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
Inventor: GONZALES JESUS E III
IPC: C07D263/50
Filed: 2004-08-09
Granted: 2011-06-30
Abstract: The present invention relates to compounds such as those of formula (I-A) inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, such as pain.
Patent AU-2004288951-B2 (AU)
Title: Detection of an electromagnetic signal
Inventor: RICHARDS THOMAS JOHN
IPC: G01S7/48
Filed: 2004-11-01
Granted: 2009-06-11
Abstract: A signal detector system (10) comprises a single signal detector (11) having a limited on-time during which any received electromagnetic signal can be assessed. The signal detector (11) receives electromagnetic signals from a single direction in space (D) through a single optical fibre (12), a signal splitter 13 which splits the collected signal between three optical paths (20, 30 and 40), and a signal combiner (14) which combines the portions of the signal transmitted by the three optical paths (20, 30 and 40) and transmits the combined signal to a signal detector input (15). Each of the optical paths (20, 30 and 40) includes a respective optical delay (21, 31 and 41) designed to delay transmission of any received signal towards the signal detector (11). In this manner the signal detector (11) will receive any signals that arrived at the optical fibre (12) during three separate periods of time.
Patent AU-2005277082-B2 (AU)
Title: Photocatalyst-induced reduction of semivolatile organic chemicals absorbed in solid materials
Inventor: WAYNE SEAMES
IPC: A62D101/26
Filed: 2005-08-22
Granted: 2011-11-24
Abstract: A method, using a photocatalyst, to accelerate the reduction of semivolatile organic chemicals absorbed into porous, solid materials. The porous, solid material having absorbed one or more semivolatile organic contaminants. The photocatalytic material located on the surface of the porous, solid material is exposed to a light source, under aerobic conditions, which excites the photocatalyst and results in the reduction of the absorbed semivolatile organic chemical contaminants.
Patent AU-2005290155-B2 (AU)
Title: Wristband or other type of band having an adjustable antenna for use with a sensor reader
Inventor: COLVIN JR ARTHUR E
IPC: A61B5/00
Filed: 2005-08-22
Granted: 2012-03-01
Abstract: The present invention provides, among other things, a sensor system, having (1) a sensor implanted in a body part of the subject, wherein the sensor has a first antenna, and (2) a sensor reader worn on the subject's body part, wherein the sensor reader has a band housing a second antenna, which is inductively coupled with the first antenna, for enabling the sensor reader to communicate with the sensor.
Patent AU-2005300253-B2 (AU)
Title: Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
Inventor: MAUREL JEAN-CLAUDE
IPC: A23L1/304
Filed: 2005-11-02
Granted: 2010-09-09
Abstract: The present invention relates to a method for the preparation of reverse micelles based on sterols, acylglycerols and metal salt and to reverse micelles obtained thereby. They are advantageously useful in the pharmaceutical and dietetic fields.
Patent AU-2005311113-B2 (AU)
Title: Improved osteotome
Inventor: RADLEY YOUNG MICHAEL JOHN
IPC: A61B17/32
Filed: 2005-12-02
Granted: 2011-07-14
Abstract: A tool (1, 31) for cutting bone comprises an elongate blade (7, 37) connectable to a generator of longitudinal-mode ultrasonic vibrations. The blade (7, 37) has two lateral cutting edges (9, 10) linked by a rounded distal tip (8). A series of triangular teeth (13) extends along each cutting edge (9, 10) and the distal tip (8). The blade (37) may taper towards each cutting edge (9,10) and the distal tip (8). A variant of the tool (21) comprises an elongate part-cylindrical blade (27) connectable to a generator of torsional-mode ultrasonic vibrations. The blade (27) has a cutting edge at its distal tip (28) provided with a plurality of triangular teeth (23). All forms of the tool (1, 21, 31) are particularly suitable for cutting cancellous bone around an implant to be removed during revision of a joint arthroplasty.
Patent AU-2005322371-B2 (AU)
Title: Complementary regenerative torque system and method of controlling same.
Inventor: JOHNSTON MATTHEW F
IPC: B60W10/06
Filed: 2005-12-12
Granted: 2011-03-17
Abstract: A complementary regenerative torque system exists for a vehicle including an engine having an accelerator pedal position sensor; a transmission unit; and a drive shaft for driving a pair of wheels for propelling the vehicle. The regenerative torque system selectively stores and supplies energy to the drive train to provide on demand complementary torque thereto. The regenerative torque system may be either hydraulic or electric in nature and may be disposed upstream or downstream of the transmission relative to the engine. A regenerative torque control module is disposed between the accelerator pedal position sensor and the engine control module and intercepts the accelerator pedal position signal and modifies it in response to the mode of operation of the regenerative torque system and forwards the modified throttle signal to the engine control module. Likewise, the regenerative torque control module intercepts signals from the engine control module and modifies the same prior to broadcasting them to the rest of the vehicle's control modules.